Citation Impact
Citing Papers
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.
1998 Standout
International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an International workshop
1999 Standout
Cochrane Database of Systematic Reviews
2003 Standout
Immunology of the antiphospholipid antibody syndrome
1996
Extracranial complications of severe head injury
1992
Diagnostic criteria and classification of clinical subtypes of adult T‐cell leukaemia‐lymphoma
1991 Standout
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
2006 Standout
Management of the obstetric antiphospholipid syndrome
2004
Accelerated Systemic Autoimmunity in the Absence of Somatic Hypermutation in 564Igi: A Mouse Model of Systemic Lupus with Knocked-In Heavy and Light Chain Genes
2017 StandoutNobel
Flexible regression models with cubic splines
1989 Standout
Drotrecogin Alfa (Activated) in Adults with Septic Shock
2012 Standout
Platelet-rich plasma: evidence to support its use
2004 Standout
Central nervous system injury-induced immune deficiency syndrome
2005 Standout
Antiphospholipid Antibody-mediated Disruption of the Annexin-V Antithrombotic Shield: a Thrombogenic Mechanism for the Antiphospholipid Syndrome
2000
An approach to the patient with retiform purpura
2011
Inflammatory response to cardiopulmonary bypass
1993 Standout
Treatment of congenital and acquired hemophilia patients by extracorporeal removal of antibodies to coagulation factors: A review of US clinical studies 1987–1990
1992
Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma
1995 Standout
Inflammation and coagulation
2010
Severe Sepsis and Septic Shock
2013 Standout
The Management of Thrombosis in the Antiphospholipid-Antibody Syndrome
1995 Standout
Treatment of Non-Hodgkin's Lymphoma
1993
Heat Shock Protein A12B Protects Vascular Endothelial Cells Against Sepsis-Induced Acute Lung Injury in Mice
2017 Standout
Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases
2020 Standout
Iron Deficiency in Infancy and Childhood
1993
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy
2020 Standout
Biology of Natural Killer Cells
1989 Standout
Effective therapy for poor-prognosis non-Hodgkin's lymphoma with 8 weeks of high-dose-intensity combination chemotherapy.
1993
The Antiphospholipid Syndrome
2002 Standout
Antiphospholipid Antibodies: Anticardiolipin and the Lupus Anticoagulant in Systemic Lupus Erythematosus (SLE) and in Non-SLE Disorders
1990
Reporting standards in venous disease: An update
1995 Standout
Prophylactic Heparin in Patients with Severe Sepsis Treated with Drotrecogin Alfa (Activated)
2007
Annexin V is critical in the maintenance of murine placental integrity
1999
Novel approaches to the management of disseminated intravascular coagulation
2000
Coagulation and sepsis
2016
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
2001 Standout
Laboratory diagnosis of the antiphospholipid syndrome
2002
Disseminated Intravascular Coagulation
1999 Standout
The immunopathology of sepsis and potential therapeutic targets
2017 Standout
New treatment strategies for disseminated intravascular coagulation based on current understanding of the pathophysiology
2004
Platelet-Rich Plasma: A Review of Biology and Applications in Plastic Surgery
2006 Standout
Inhibitor to factor V after exposure to fibrin sealant during cardiac surgery in a two‐year‐old child
1994
Antiphospholipid syndrome and the skin
1997
Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies
2005 Standout
Antiphospholipid antibodies and preeclampsia: a case-control study
2001
Major prognostic factors of adult patients with advanced T-cell lymphoma/leukemia.
1988
The immunopathogenesis of sepsis
2002 StandoutNature
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Redo cardiac surgery: late bleeding complications from topical thrombin-induced factor V deficiency.
1993
Many faces of lupus anticoagulants
1998
Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis
2002 Standout
The natural history of factor VIII:C inhibitors in patients with hemophilia A: a national cooperative study. II. Observations on the initial development of factor VIII:C inhibitors
1988
Socioeconomic Status and Child Development
2002 Standout
Acquired immunodeficiency syndrome-related lymphoma [see comments]
1992
Immunology and Clinical Importance of Antiphospholipid Antibodies
1991
Pneumococcal Vaccine: Clinical Efficacy and Effectiveness
1982
Inhibition of platelet prothrombinase activity by a lupus anticoagulant
1983
Acquired immunodeficiency syndrome-related lymphoma [see comments]
1992
Identification of Major Prognostic Subgroups of Patients with Large-Cell Lymphoma Treated with m-BACOD or M-BACOD
1986
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack
2006 Standout
The Biochemistry and Pathophysiology of the Contact System of Plasma
1982
Reactive Lymphoid Hyperplasia with Single Class (Monoclonal) Surface Immunoglobulin
1983
A meta-analysis of randomized controlled trials
2019 Standout
Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C.
1993 Standout
Towards Definition, Clinical and Laboratory Criteria, and a Scoring System for Disseminated Intravascular Coagulation
2001 Standout
Systemic Lupus Erythematosus
1975
ANTI-IDIOTYPIC SUPPRESSION OF AUTOANTIBODIES TO FACTOR VIII (ANTIHAEMOPHILIC FACTOR) BY HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN
1984
Annexins: From Structure to Function
2002 Standout
REVERSIBILITY OF LYMPHOMAS AND LYMPHOPROLIFERATIVE LESIONS DEVELOPING UNDER CYCLOSPORIN-STEROID THERAPY
1984 Standout
Placebo controlled pneumococcal immunization in patients with bronchogenic carcinoma
1986
A Randomized Trial Comparing Intravenous Immune Globulin and Plasma Exchange in Guillain–Barré Syndrome
1992 Standout
Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains.
1978 Standout
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
Human Cd4+ T Lymphocytes Consistently Respond to the Latent Epstein-Barr Virus Nuclear Antigen Ebna1
2000 StandoutNobel
Studies on Phospholipids in the Action of a Lupus Coagulation Inhibitor
1975
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
2010 Standout
Thrombosis in Patients with the Lupus Anticoagulant
1980
Development of antibodies to thrombin and factor V with recurrent bleeding in a patient exposed to topical bovine thrombin
1990
Lysis of lymphoma cells by autologous and allogeneic natural killer cells
1985
Platelet Function and Coagulation Profile in Lupus Erythematosus
1974
Guidelines for the management of hemophilia
2012 Standout
The influence of systemic lupus erythematosus on fetal development: Cognitive, behavioral, and health trends
1997
Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas
1999 Standout
Platelet Physiology and Abnormalities of Platelet Function
1975 Standout
Works of DI Feinstein being referenced
Immunoblastic sarcoma of T-cell versus B-cell origin: I. Clinical features
1981
Relationship of contact activation cofactor (CAC) procoagulant activity to kininogen
1977
Acquired inhibitors of blood cagulation
1972
Diagnosis and management of disseminated intravascular coagulation: the role of heparin therapy
1982
Lupus anticoagulant, anticardiolipin antibodies, fetal loss, and systemic lupus erythematosus [editorial; comment]
1992
Factor XI activity and factor XI antigen in homozygous and heterozygous factor XI deficiency
1976
Quantitative anisocytosis as a discriminant between iron deficiency and thalassemia minor
1979
Immunoblastic sarcoma of T-cell versus B-cell origin: I. Clinical features
1981
Acquired inhibitors of blood coagulation.
1972
Diagnosis and management of disseminated intravascular coagulation: the role of heparin therapy
1982
Successful therapy of convoluted T-lymphoblastic lymphoma in the adult
1983
Use and efficacy of pneumococcal vaccine in patients with Hodgkin disease
1979